SciSparc: Cutting-Edge Drug Combinations for Large, Global Unmet Needs

Mar. 21, 2022
SciSparc (Nasdaq: SPRC) is a specialty pharmaceutical company developing unique technologies for treatment of central nervous system disorders. The proprietary compounds capitalize on the biochemistry of receptors that specialize in modulating the central nervous system (CNS) to create therapeutics that mitigate the adverse symptoms associated with CNS disorders. Visit SPRCinfo.com to learn more.

 Read More

Bloomberg TV Show

CEO Interviews

"I work with many of the companies that would be RedChip companies. And we certainly ascribe to the same view that the RedChip Companies do, which is Discovering Tomorrow's Blue Chips Today."

  • Bob McCooey, Senior Vice President, NASDAQ Stock Market